Sulfonylalkanoylamino hydroxyethlamino sulfonamides useful as retroviral protease inhibitors
US5508294A · kind A · utility
24Cited by
13References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 31, 1995 |
| Grant date | Apr 16, 1996 |
| Priority date | — |
| Expiry date | May 31, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C317/44
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Sulfonamide-containing hydroxethylamine compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.